Caricamento...
Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes
BACKGROUND: The assessment of real-world effectiveness of immunomodulatory medications for multisystem inflammatory syndrome in children (MIS-C) may guide therapy. METHODS: We analyzed surveillance data on inpatients younger than 21 years of age who had MIS-C and were admitted to 1 of 58 U.S. hospit...
Salvato in:
| Pubblicato in: | N Engl J Med |
|---|---|
| Autori principali: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Massachusetts Medical Society
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8220972/ https://ncbi.nlm.nih.gov/pubmed/34133855 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2102605 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|